These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38228858)

  • 1. Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants.
    Reuschl AK; Thorne LG; Whelan MVX; Ragazzini R; Furnon W; Cowton VM; De Lorenzo G; Mesner D; Turner JLE; Dowgier G; Bogoda N; Bonfanti P; Palmarini M; Patel AH; Jolly C; Towers GJ
    Nat Microbiol; 2024 Feb; 9(2):451-463. PubMed ID: 38228858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.
    Richardson SI; Mzindle N; Motlou T; Manamela NP; van der Mescht MA; Lambson BE; Everatt J; Amoako DG; Balla S; von Gottberg A; Wolter N; de Beer Z; de Villiers TR; Bodenstein A; van den Berg G; Abdullah F; Rossouw TM; Boswell MT; Ueckermann V; Bhiman JN; Moore PL
    J Virol; 2024 Jul; 98(7):e0067824. PubMed ID: 38953380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.
    Essink BJ; Shapiro C; Isidro MGD; Bradley P; Pragalos A; Bloch M; Santiaguel J; Frias MV; Miyakis S; Alves de Mesquita M; Berrè S; Servais C; Waugh N; Hoffmann C; Baba E; Schönborn-Kellenberger O; Wolz OO; Koch SD; Ganyani T; Boutet P; Mann P; Mueller SO; Ramanathan R; Gaudinski MR; Vanhoutte N
    Hum Vaccin Immunother; 2024 Dec; 20(1):2408863. PubMed ID: 39422261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of enhanced innate immune evasion by SARS-CoV-2.
    Thorne LG; Bouhaddou M; Reuschl AK; Zuliani-Alvarez L; Polacco B; Pelin A; Batra J; Whelan MVX; Hosmillo M; Fossati A; Ragazzini R; Jungreis I; Ummadi M; Rojc A; Turner J; Bischof ML; Obernier K; Braberg H; Soucheray M; Richards A; Chen KH; Harjai B; Memon D; Hiatt J; Rosales R; McGovern BL; Jahun A; Fabius JM; White K; Goodfellow IG; Takeuchi Y; Bonfanti P; Shokat K; Jura N; Verba K; Noursadeghi M; Beltrao P; Kellis M; Swaney DL; García-Sastre A; Jolly C; Towers GJ; Krogan NJ
    Nature; 2022 Feb; 602(7897):487-495. PubMed ID: 34942634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
    Bouhaddou M; Reuschl AK; Polacco BJ; Thorne LG; Ummadi MR; Ye C; Rosales R; Pelin A; Batra J; Jang GM; Xu J; Moen JM; Richards AL; Zhou Y; Harjai B; Stevenson E; Rojc A; Ragazzini R; Whelan MVX; Furnon W; De Lorenzo G; Cowton V; Syed AM; Ciling A; Deutsch N; Pirak D; Dowgier G; Mesner D; Turner JL; McGovern BL; Rodriguez ML; Leiva-Rebollo R; Dunham AS; Zhong X; Eckhardt M; Fossati A; Liotta NF; Kehrer T; Cupic A; Rutkowska M; Mena I; Aslam S; Hoffert A; Foussard H; Olwal CO; Huang W; Zwaka T; Pham J; Lyons M; Donohue L; Griffin A; Nugent R; Holden K; Deans R; Aviles P; Lopez-Martin JA; Jimeno JM; Obernier K; Fabius JM; Soucheray M; Hüttenhain R; Jungreis I; Kellis M; Echeverria I; Verba K; Bonfanti P; Beltrao P; Sharan R; Doudna JA; Martinez-Sobrido L; Patel AH; Palmarini M; Miorin L; White K; Swaney DL; Garcia-Sastre A; Jolly C; Zuliani-Alvarez L; Towers GJ; Krogan NJ
    Cell; 2023 Oct; 186(21):4597-4614.e26. PubMed ID: 37738970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective clinical performance of CoVarScan in identifying SARS-CoV-2 Omicron subvariants.
    Zhu K; Sah M; Mahimainathan L; Liu Y; Xing C; Roush K; Clark A; SoRelle J
    Microbiol Spectr; 2024 Dec; ():e0138524. PubMed ID: 39660915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ensemble-Based Mutational Profiling and Network Analysis of the SARS-CoV-2 Spike Omicron XBB Lineages for Interactions with the ACE2 Receptor and Antibodies: Cooperation of Binding Hotspots in Mediating Epistatic Couplings Underlies Binding Mechanism and Immune Escape.
    Raisinghani N; Alshahrani M; Gupta G; Verkhivker G
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotyping the virulence of SARS-CoV-2 variants in hamsters by digital pathology and machine learning.
    Meehan GR; Herder V; Allan J; Huang X; Kerr K; Mendonca DC; Ilia G; Wright DW; Nomikou K; Gu Q; Molina Arias S; Hansmann F; Hardas A; Attipa C; De Lorenzo G; Cowton V; Upfold N; Palmalux N; Brown JC; Barclay WS; Filipe ADS; Furnon W; Patel AH; Palmarini M
    PLoS Pathog; 2023 Nov; 19(11):e1011589. PubMed ID: 37934791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded immune imprinting and neutralization spectrum by hybrid immunization following breakthrough infections with SARS-CoV-2 variants after three-dose vaccination.
    Jia T; Wang F; Chen Y; Liao G; Xu Q; Chen J; Wu J; Li N; Wang L; Yuan L; Wang D; Xie Q; Luo C; Luo H; Wang Y; Chen Y; Shu Y
    J Infect; 2024 Dec; 89(6):106362. PubMed ID: 39608577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid spread of the SARS-CoV-2 Omicron XDR lineage derived from recombination between XBB and BA.2.86 subvariants circulating in Brazil in late 2023.
    Arantes I; Ito K; Gomes M; Carvalho FCd; Ferreira de Almeida WA; Khouri R; Miyajima F; Wallau GL; Naveca FG; Pereira EC; ; Mendonça Siqueira M; Resende PC; Bello G
    Microbiol Spectr; 2024 Nov; ():e0119324. PubMed ID: 39611827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant.
    Khan K; Lustig G; Römer C; Reedoy K; Jule Z; Karim F; Ganga Y; Bernstein M; Baig Z; Jackson L; Mahlangu B; Mnguni A; Nzimande A; Stock N; Kekana D; Ntozini B; van Deventer C; Marshall T; Manickchund N; Gosnell BI; Lessells RJ; Karim QA; Abdool Karim SS; Moosa MS; de Oliveira T; von Gottberg A; Wolter N; Neher RA; Sigal A
    Nat Commun; 2023 Dec; 14(1):8078. PubMed ID: 38057313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C→U transition biases in SARS-CoV-2: still rampant 4 years from the start of the COVID-19 pandemic.
    Simmonds P
    mBio; 2024 Dec; 15(12):e0249324. PubMed ID: 39475243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids.
    Kakizaki M; Hashimoto R; Nagata N; Yamamoto T; Okura T; Katoh H; Kitai Y; Akahori Y; Shirato K; Ryo A; Takayama K; Takeda M
    J Virol; 2024 Nov; ():e0185324. PubMed ID: 39601592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Expansion of SARS-CoV-2 Variants of Concern: Dispersal Patterns and Influence of Air Travel.
    Tegally H; Wilkinson E; Martin D; Moir M; Brito A; Giovanetti M; Khan K; Huber C; Bogoch II; San JE; Tsui JL; Poongavanan J; Xavier JS; Candido DDS; Romero F; Baxter C; Pybus OG; Lessells R; Faria NR; Kraemer MUG; de Oliveira T
    medRxiv; 2022 Nov; ():. PubMed ID: 36451885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse model.
    Alves RPDS; Wang YT; Mikulski Z; McArdle S; Shafee N; Valentine KM; Miller R; Verma SK; Batiz FAS; Maule E; Nguyen MN; Timis J; Mann C; Zandonatti M; Alarcon S; Rowe J; Kronenberg M; Weiskopf D; Sette A; Hastie K; Saphire EO; Festin S; Kim K; Shresta S
    Antiviral Res; 2023 Apr; 212():105580. PubMed ID: 36940916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic.
    Akerman A; Fichter C; Milogiannakis V; Esneau C; Silva MR; Ison T; Lopez JA; Naing Z; Caguicla J; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Boss T; Condylios A; Yeang M; Sato K; Bartlett NN; Darley D; Matthews G; Stark DJ; Promsri S; Rawlinson WD; Murrell B; Kelleher AD; Dwyer D; Sintchenko V; Kok J; Ellis S; Marris K; Knight E; Hoad VC; Irving DO; Gosbell I; Brilot F; Wood J; Aggarwal A; Turville SG
    EBioMedicine; 2024 Dec; 110():105415. PubMed ID: 39549677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benchmark Investigation of SARS-CoV-2 Mutants' Immune Escape with 2B04 Murine Antibody: A Step Towards Unraveling a Larger Picture.
    Kapusta K; McGowan A; Banerjee S; Wang J; Kolodziejczyk W; Leszczynski J
    Curr Issues Mol Biol; 2024 Nov; 46(11):12550-12573. PubMed ID: 39590339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.
    Descamps D; Peres de Oliveira A; Gonnin L; Madrières S; Fix J; Drajac C; Marquant Q; Bouguyon E; Pietralunga V; Iha H; Morais Ventura A; Tangy F; Vidalain PO; Eléouët JF; Galloux M
    J Virol; 2021 Oct; 95(22):e0091221. PubMed ID: 34431698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human placental cells are resistant to SARS-CoV-2 infection and replication.
    Yoshida N; Thomas JR; Appios A; Brember MP; Aye ILMH; Edgar JR; Firth AE; Chung BYW; McGovern N; Stewart H
    Wellcome Open Res; 2024; 9():209. PubMed ID: 39640372
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.